DengYueMed is a China-focused pharmaceutical export wholesaler headquartered in Hong Kong. We offer more than 30,000 types of medicines, covering Chinese innovative drugs, oncology, hematology, orphan drugs, and a wide range of hospital-needed pharmaceuticals. Through our extensive international trade network, we are committed to ensuring the global supply of high-quality medicines to meet the healthcare needs of different regions. We consistently prioritize drug safety, efficacy, and stable quality, ensuring that all our products comply with international certification standards.
-
5 Publicações
-
2 fotos
-
0 Vídeos
-
Outro
-
Seguido por 0 pessoas
Atualizações recentes
-
The Rise of China’s Innovative Oncology Drugs: A New Global Supply OpportunityIn recent years, China has rapidly emerged as a key player in the global pharmaceutical landscape, particularly in oncology innovation. Once known primarily for generic drug manufacturing, the country is now producing cutting-edge targeted therapies and biologics that are reshaping cancer treatment worldwide. Platforms like DengYueMed oncology drug platform are helping showcase this...0 Comentários 0 Compartilhamentos 234 Visualizações 0 AnteriorFaça o login para curtir, compartilhar e comentar!
-
Renewed Hope: China's Advancing ADC Therapies and the 2025 Approvals Illuminating the Path for Cancer WarriorsIn a world where cancer remains a formidable enemy, every scientific advance becomes a beacon of hope for millions of patients fighting day by day. As an editor at DengYueMed, a company that, with its commitment to excellence, innovation, sustainability, and social responsibility—built on the foundations of quality, compliance, and integrity—actively participates in the global...0 Comentários 0 Compartilhamentos 990 Visualizações 0 Anterior
-
China's Innovative Drug Export: Accelerating a New Era of GlobalizationIn the pharmaceutical landscape of 2025, Chinese innovative drug companies are advancing onto the international stage at an unprecedented pace. Over the past 24 hours, several key developments have highlighted this trend, showcasing not only the innovative prowess of Chinese firms but also the deepening of global collaborations. According to the latest drug price registration system launched by...0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
-
0 Comentários 0 Compartilhamentos 816 Visualizações 0 Anterior
-
0 Comentários 0 Compartilhamentos 821 Visualizações 0 Anterior
Mais stories